Tagged with Strategy

Greece Stavros Theodorakis, managing director of Chiesi Greece & Cyprus and vice president of the Hellenic Association of Pharmaceutical Companies (SFEE), pinpoints the factors that successfully carried the company through the Greek crisis, while highlighting co-branding and co-promotion as the key strategies behind Chiesi’s leading position in the domestic respiratory market.…

Ireland Philip Martin, founder and CEO of Cora Systems in Ireland, explains why his company is ideally positioned to help the pharmaceutical industry increase efficiency and save costs through their agile, flexible and intuitive project management software solutions. “Along with tech improvements, incredible new complexity in how the industry operates has…

Greece Starting as a one-man-show when he began the Greek affiliate in 2009, Orion Pharma’s General Manager, Thanassis Panopoulos discusses the company’s high level of resiliency, the challenges of bringing a Finnish company to Greece, communicating the value of their life-saving products to relevant stakeholders, as well as their objective to…

Switzerland Working to stay ahead in the highly competitive medical device field, Boston Scientific’s Philippe Hügli launched a Customer Insight Initiative in Switzerland which has served as a pilot for the European organization.  Considering the immense competition in the medical device industry today, what do you see as the key trends…

Greece Carrying the legacy of an accomplished Greek family business, Anfarm CEO Eugenia Nicolaou speaks proudly about the company’s evolution, how Anfarm is maintaining a sustainable business model in the midst of the economic crisis, and how it is building a stronger presence in the international landscape. Anfarm is a Greek…

Switzerland Lupin’s EMEA President Thierry Volle explains that to fuel growth in the EMEA region, Lupin is investing heavily in transforming the business from a generics company into a specialty pharma player. Mr Volle, given your background in the innovative pharma sector, what was it that attracted you to join Lupin?…

Switzerland Soho Flordis International (SFI) has the ambition to be a global leader in premium natural healthcare solutions, and is leveraging extensive M&A activities to reach this goal. Group head of business development Michele Genovesi discusses the group’s aims and strategy, and explains how Ticino based Ginsana SA – now SFI…

Switzerland Italian-speaking Swiss canton Ticino outperforms most regions within Europe, yet still lags behind the high-flying cantons of Northern Switzerland. Stefano Rizzi, director of the canton’s economic division, discusses its economic development strategy and the important role that the life sciences sector plays within it. Ticino is the Italian-speaking region of…

Ireland Grünenthal Ireland’s General Manager discusses the incredible growth of the Irish affiliate over the past twelve years, their comprehensive pain portfolio, the innovation they are bringing as pain specialists to the industry, and his strategy for increasing revenues in the next five years.  You were the founder of Grünenthal’s Irish…

Mexico Juan Francisco Hernández, general manager of Latin America at Wockhardt, showcases the added value of the company to the entire region based on quality, safety and cost-effective medicines targeting diabetes, CNS and anti-infective areas. Could you introduce yourself to our international readers as well as the key activities and operations…

Angelini Having joined the company at the onset of its presence in the Greek market, Angelini Pharma Hellas’s General Manager, Panagiotis Giannouleas, speaks about the success of the company’s transitional period, how Angelini is maneuvering through current local uncertainties, and his overarching vision for the future. Mr. Giannouleas, having hailed from…

Switzerland LEO Pharma’s Country Lead for Switzerland, Patrick Brunner, discusses the skincare specialist’s most important products, the Swiss affiliate’s significance to the global group, and the exciting new partnership with AstraZeneca. LEO Pharma Switzerland was established back in 1991 meaning that, last year, you celebrated 25 years of in-country operations. Could…